About
LYO-X AG is a Basel-based company that provides modelling, simulation, and systems pharmacology services for preclinical and clinical development of biotherapeutics. It serves customers globally from Basel, Switzerland, and was founded in 2014. The company has 14 employees and has served more than 200 customers globally.
Services
Strategic consultancy
Provides strategic consultancy for the development and transition of biotherapeutics through preclinical and clinical stages.
PK/PD modeling
Provides PK/PD modeling to support preclinical and clinical development of biotherapeutics.
Phase I PK/PD analysis
Performs Phase I study PK, PD, and biomarker analysis to support dose escalation and study interpretation.
On Demand Phase I PK/PD Analysis
Performs phase I study PK, PD, and biomarker analysis to guide dose escalation and study interpretation.
Target assessment
Assesses targets to support early development decisions.
Format selection
Supports selection of biologic formats for development programs.
Candidate selection
Helps select candidate biotherapeutics for progression.
Preclinical PK/PD and toxicology study
Supports preclinical PK/PD and toxicology study planning and interpretation.
5 more services
- First dose in human / MABEL
- Paediatric dose finding
- Clinical dose finding studies
- Due diligence
- Biobetter design and benchmarking
Capabilities
- Assays and studies
- PK/PD
- Antibodies
- Toxicology
- PK analysis
- PD analysis
- Biomarker analysis
- PK/PD modeling
- Systems pharmacology
Modalities and species
- Modalities
- Antibody
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Industries served
- Biotech
Company
- Type
- CRO
- Founded
- 2014
- Size
- 11-50 employees
Locations
- Address
- Holbeinstrasse 75 4051 Basel Switzerland LYO-X is part of the iBx Network: In
- Serves
- Globally
Contacts
- Phone
- +41 79 766 52 70